7 research outputs found

    In-Situ Growth of NiFe<sub>2</sub>O<sub>4</sub>/2D MoS<sub>2</sub> p‑n Heterojunction Immobilizing Palladium Nanoparticles for Enhanced Visible-Light Photocatalytic Activities

    No full text
    Solar energy is considered as a green and abundant energy for catalytic reactions. In this work, a magnetically recoverable NiFe<sub>2</sub>O<sub>4</sub>/2D MoS<sub>2</sub>–Pd nanocomposite is successfully synthesized via a simple one-pot hydrothermal method. The intimate interfacial contact between NiFe<sub>2</sub>O<sub>4</sub> nanocubes and corrugated MoS<sub>2</sub> nanosheets forms the NiFe<sub>2</sub>O<sub>4</sub>/2D MoS<sub>2</sub> p-n heterojunction, while plasmonic Pd nanoparticles are uniformly immobilized on the surface of it. Dye degradation and Suzuki-Miyaura coupling reaction are employed to evaluate the photocatalytic activity of the NiFe<sub>2</sub>O<sub>4</sub>/2D MoS<sub>2</sub>–Pd nanocomposite. Significantly, both dye degradation and Suzuki-Miyaura coupling reaction can be efficiently performed in a short time under mild conditions. In comparison, the physically mixed NiFe<sub>2</sub>O<sub>4</sub>+2D MoS<sub>2</sub> heterojunction immobilizing palladium nanoparticles shows poor photocatalytic activity. Photocatalytic results demonstrate that the in situ formation of NiFe<sub>2</sub>O<sub>4</sub>/2D MoS<sub>2</sub> p-n heterojunction greatly improves the visible-light absorption and facilitates the transferring of photogenerated electrons and holes. Moreover, Pd nanoparticles as the electron reservoirs can further suppress the electron–hole recombination and enhance the photocatalytic activity. The construction of semiconductive p-n heterojunction to immobilize metal nanocatalysts will be an inspiration for other useful photocatalytic applications

    Dual-Functional Starfish-like P‑Doped Co–Ni–S Nanosheets Supported on Nickel Foams with Enhanced Electrochemical Performance and Excellent Stability for Overall Water Splitting

    No full text
    Dual-functional electrocatalysts have recently been reported to improve the conversion and storage of energy generated from overall water splitting in alkaline electrolytes. Herein, for the first time, a shape-controlled synthesis of starfish-like Co–Ni–S nanosheets on three-dimensional (3D) hierarchically porous nickel foams (Co–Ni–S/NF) via a one-step hydrothermal method was developed. The influence of reaction time on the nanosheet structure and properties was intensively studied. After 11 h reaction, the Co–Ni–S/NF-11 sample displays the most regular structure of nanosheets and the most outstanding electrochemical properties. As to water splitting, hydrogen evolution reaction (HER) and oxygen evolution reaction (OER) required overpotentials of 284.3 and 296 mV, respectively, to provide a current density of 100 mA cm<sup>–2</sup>. The marvelous electrochemical performance can be attributed to the conductive networks of 3D layered porous nickel skeletons that are highly interconnected, which provided a large specific area and highly active sites. To further enhance the electrochemical performances of the electrocatalyst, the influence of the doping of the P element was also studied. The results proved that the P-doped Co–Ni–S/NF maintains the starfish structure and demonstrates outstanding properties, providing a current density of 100 mA cm<sup>–2</sup> with only 187.4 and 292.2 mV overpotentials for HER and OER, respectively. It exhibited far more excellent properties than reported dual-functional electrocatalysts. Additionally, when used as an overall water-splitting catalyst, P–Co–Ni–S/NF can provide a 10 mA cm<sup>–2</sup> current density at a given cell voltage of 1.60 V in 1 M KOH, which is competitive to the best-known electrocatalysts, with high long-term stability

    Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells

    No full text
    <p>Colorectal cancer (CRC) is the third leading cause of cancer-related deaths worldwide. 5-fluorouracil (5-FU)-based chemotherapeutic regimens are routinely used for the treatment of patients with CRC. However, recurrence and chemotherapeutic drug resistance limit the survival rates of patients with CRC. DNA methylation participates in diverse cellular processes by regulating the transcription of a large number of genes expression, cell division, apoptosis, cell adhesion and differentiation, and metabolism, thus it might mediate chemoresistance. Using an Illumina Infinium HD Assay, DNA methylation levels in a human 5-FU-resistant HCT-8 CRC cell line (HCT-8/FU) and its progenitor cell line HCT-8 were analysed. A total of 16,580 differentially methylated genes were identified, of which 8885 were hypermethylated and 7695 were hypomethylated in resistant cells. Among these genes, <i>NME2</i> (nucleoside diphosphate kinase 2) exhibited a significant difference in methylation between cell lines and has known roles in gastric cancer and breast cancer; accordingly, we hypothesized that it plays a role in acquired resistance in CRC. Knockdown of <i>NME2</i> restored 5-FU sensitivity in 5-FU-resistant CRC cells, reduced cell survival and increased cell apoptosis; and overexpression of <i>NME2</i> in HCT-8 cells results in the acquisition of resistance to 5-FU, this alteration enhanced HCT-8 cells growth abilities and reduced apoptosis. These findings suggest that <i>NME2</i> mediates chemoresistance to 5-FU in CRC and that specific <i>NME2</i> inhibition could optimize 5-FU-based chemotherapy of CRC.</p

    Controlled Electrodeposition Synthesis of Co–Ni–P Film as a Flexible and Inexpensive Electrode for Efficient Overall Water Splitting

    No full text
    Synthesis of highly efficient and robust catalysts with earth-abundant resources for overall water splitting is essential for large-scale energy conversion processes. Herein, a series of highly active and inexpensive Co–Ni–P films were fabricated by a one-step constant current density electrodeposition method. These films were demonstrated to be efficient bifunctional catalysts for both H<sub>2</sub> and O<sub>2</sub> evolution reactions (HER and OER), while deposition time was deemed to be the crucial factor governing electrochemical performance. At the optimal deposition time, the obtained Co–Ni–P-2 catalyst performed remarkably for both HER and OER in alkaline media. In particular, it requires −103 mV overpotential for HER and 340 mV for OER to achieve the current density of 10 mA cm<sup>–2</sup>, with corresponding Tafel slopes of 33 and 67 mV dec<sup>–1</sup>. Moreover, it outperforms the Pt/C//RuO<sub>2</sub> catalyst and only needs −160 mV (430 mV) overpotential for HER (OER) to achieve 200 mA cm<sup>–2</sup> current density. Co–Ni–P electrodes were also conducted for the proof-of-concept exercise, which were proved to be flexible, stable, and efficient, further opening a new avenue for rapid synthesis of efficient, flexible catalysts for renewable energy resources

    Controlled Electrodeposition Synthesis of Co–Ni–P Film as a Flexible and Inexpensive Electrode for Efficient Overall Water Splitting

    No full text
    Synthesis of highly efficient and robust catalysts with earth-abundant resources for overall water splitting is essential for large-scale energy conversion processes. Herein, a series of highly active and inexpensive Co–Ni–P films were fabricated by a one-step constant current density electrodeposition method. These films were demonstrated to be efficient bifunctional catalysts for both H<sub>2</sub> and O<sub>2</sub> evolution reactions (HER and OER), while deposition time was deemed to be the crucial factor governing electrochemical performance. At the optimal deposition time, the obtained Co–Ni–P-2 catalyst performed remarkably for both HER and OER in alkaline media. In particular, it requires −103 mV overpotential for HER and 340 mV for OER to achieve the current density of 10 mA cm<sup>–2</sup>, with corresponding Tafel slopes of 33 and 67 mV dec<sup>–1</sup>. Moreover, it outperforms the Pt/C//RuO<sub>2</sub> catalyst and only needs −160 mV (430 mV) overpotential for HER (OER) to achieve 200 mA cm<sup>–2</sup> current density. Co–Ni–P electrodes were also conducted for the proof-of-concept exercise, which were proved to be flexible, stable, and efficient, further opening a new avenue for rapid synthesis of efficient, flexible catalysts for renewable energy resources

    Liquid Phase Exfoliation of Two-Dimensional Materials by Directly Probing and Matching Surface Tension Components

    No full text
    Exfoliation of two-dimensional (2D) materials into mono- or few layers is of significance for both fundamental studies and potential applications. In this report, for the first time surface tension components were directly probed and matched to predict solvents with effective liquid phase exfoliation (LPE) capability for 2D materials such as graphene, h-BN, WS<sub>2</sub>, MoS<sub>2</sub>, MoSe<sub>2</sub>, Bi<sub>2</sub>Se<sub>3</sub>, TaS<sub>2</sub>, and SnS<sub>2</sub>. Exfoliation efficiency is enhanced when the ratios of the surface tension components of the applied solvent is close to that of the 2D material in question. We enlarged the library of low-toxic and common solvents for LPE. Our study provides distinctive insight into LPE and has pioneered a rational strategy for LPE of 2D materials with high yield

    Image_3_Neoadjuvant tislelizumab and tegafur/gimeracil/octeracil (S-1) plus oxaliplatin in patients with locally advanced gastric or gastroesophageal junction cancer: Early results of a phase 2, single-arm trial.tif

    No full text
    BackgroundRecently, the combination of immunotherapy with chemotherapy has been recommended as first-line treatment of metastatic gastric/gastroesophageal junction (G/GEJ) in the clinical guidelines of many countries; the therapeutic potential of this application needs to be further investigated for neoadjuvant therapy of advanced G/GEJ cancer patients.MethodsWe performed a prospective, single-arm, open-label, phase 2 trial of the PD-1 inhibitor tislelizumab combined with S-1 plus oxaliplatin (SOX) in patients with advanced LAG/GEJ cancer. All patients underwent the three-cycle (21 days/cycle) treatment except for one patient who underwent two cycles. The primary endpoints were tumor major pathology response (MPR) and other events of tumor response assessed by the RECIST 1.1 and Becker criteria. Moreover, we constructed a few-shot learning model to predict the probability of MPR, which could screen those patients who might benefit from the neoadjuvant immunotherapy–chemotherapy scheme. This study was registered at https://clinicaltrials.gov/ct2/show/NCT0-4890392.ResultsThirty-two patients were enrolled; 17 patients (53.1%) achieved MPR (≤10% viable tumor cells) after treatment, and among them, 8 (25.0%) had a pathological complete response (pCR). The 1-year overall survival (OS) rate was 91.4% and the 1-year recurrence-free survival (RFS) rate was 90.0%. Adverse events occurred in 24 patients (65.6%) and grade III–IV adverse events were observed in 4 patients (12.5%) during the neoadjuvant period. Furthermore, we found commonly used preoperative assessment tools such as CT and EUS, which presented limited accuracy of tumor therapeutic response in this study; thus, we developed a therapeutic response predictive model that consisted of TNFα, IFNγ, IL-10, CD4, and age of patient, and the AUC of this FSL model was 0.856 (95% CI: 0.823–0.884).DiscussionOur study showed that the neoadjuvant PD-1 inhibitor tislelizumab combined with SOX had promising application potential and presented no increasing treatment-related adverse events in patients with advanced G/GEJ cancer. Moreover, the predictive model could help therapists to evaluate the therapeutic response of this scheme accurately.Clinical Trial Registrationhttps://clinicaltrials.gov/ct2/show/NCT0-4890392, identifier [NCT04890392].</p
    corecore